Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents
- 1 April 2012
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (7), 2434-2439
- https://doi.org/10.1016/j.bmcl.2012.02.023
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- How were new medicines discovered?Nature Reviews Drug Discovery, 2011
- Drug development for CNS disorders: strategies for balancing risk and reducing attritionNature Reviews Drug Discovery, 2007
- Chapter 3. Recent advances in development of novel analgesicsPublished by Elsevier BV ,2000
- Emerging Molecular Approaches to Pain TherapyJournal of Medicinal Chemistry, 1999
- Side effects of morphine administration in cancer patientsCancer Nursing, 1998
- The Role of Descending Noradrenergic and Serotoninergic Pathways in the Modulation of Nociception: Focus on Receptor MultiplicityPublished by Springer Science and Business Media LLC ,1997
- N-Substituted Oxazolo[5,4-b]pyridin-2(1H)-ones: A New Class of Non-Opiate Antinociceptive AgentsJournal of Medicinal Chemistry, 1995
- 1-(3-Methyl-2-benzoxazolinone-6-yl)-2-(4-substituted piperazine-1-yl)ethanones and ethanols: analgesic and antiinflammatory activitiesEuropean Journal of Medicinal Chemistry, 1993
- Novel nonopioid non-antiinflammatory analgesics: 3-(aminoalkyl)- and 3-[(4-aryl-1-piperazinyl)alkyl]oxazolo[4,5-b]pyridin-2(3H)-onesJournal of Medicinal Chemistry, 1993
- Prevention of opioid side effectsJournal of Pain and Symptom Management, 1990